Zhejiang Orient Gene Biotech Co., Ltd (Orient Gene), a gene therapy-focused biotech products manufacturer, made a stellar debut on the Shanghai Stock Exchange STAR Market with its scrip soaring 328 per cent and its market cap exceeding 11 billion yuan ($1.6 billion) in opening trade on Wednesday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
